CHEM21 – Chemical Manufacturing Methods for the 21st Century Pharmaceutical Industries

Leading organisations:
GlaxoSmithKline and The University of Manchester

Timeframe:
2012-2016

Geographic Area:
Pan-European

Objectives:

The aim is to develop sustainable biological and chemical alternatives to finite materials, such as precious metals, which are currently used as catalysts in the manufacture of medicines.


Target audience:
Pharmaceutical manufacturers and Scientists

Area of interest:
Pharmaceutical manufacturing

Activities:

1) CHEM21 is a project that will develop a broad based portfolio of sustainable technologies for green chemical intermediate manufacture aimed at the pharmaceutical industry
2) Initially working with the EFPIA members the collaborators of CHEM21 will analyse a number of projects that are in development to decide which the priorities are for technology development. This analysis will also be used to update the literature of green technology based on updating previous papers.
3) The technology being developed is divided into three work packages based on chemical catalysis and synthetic methods, biocatalysis and synthetic biology
4) Finally the outcomes of the efforts described will be incorporated into education and training efforts to produce the next generation of process chemists with a good understanding of green and sustainable metrics


Communication material:

Return to search form.

HCWH Europe gratefully acknowledges the financial support of the European Commission (EC)’s LIFE+ programme, the Federal Ministry for the Environment, Nature Conservation, and Nuclear Safety (BMU) Germany, and the German Environment Agency (UBA). HCWH Europe is solely responsible for the content of this project and related materials. The views expressed do not reflect the official views of the EC, BMU, or UBA.